Literature DB >> 7996002

Decay of transplacental human immunodeficiency virus type 1 antibodies in neonates and infants.

P Palasanthiran1, P Robertson, J B Ziegler, G G Graham.   

Abstract

Transplacental human immunodeficiency virus (HIV) antibodies from 11 uninfected and 3 infected infants of HIV-seropositive mothers were measured using end point titration of twofold dilutions of sera by a particle-agglutination method. Four or more sequential serum samples from each infant were collected between birth and age > or = 14 months and analyzed. Linear regression of log2 antibody titers of uninfected infants plotted against age (days) showed an exponential decay in maternal HIV antibodies. The mean half-life of passive HIV antibodies was 23.1 +/- SD 4.2 days (range, 18.2-29.3; 95% confidence interval, 20.2-26.0). The median age of clearance of maternal HIV antibodies was 13.3 months (range, 10.4-15.6). A model assuming first-order exponential decay and production of HIV antibodies was fitted to the time course of antibody titers of the infected infants. Minimal titers in each infected infant occurred at 5.5, 4.9, and 4.0 months, and doubling times of HIV antibodies from that point ranged from 16.8 to 31.4 days.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7996002     DOI: 10.1093/infdis/170.6.1593

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Pediatric human immunodeficiency virus screening in an African district hospital.

Authors:  A J De Baets; B S Edidi; M J Kasali; G Beelaert; W Schrooten; A Litzroth; P Kolsteren; D Denolf; K Fransen
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

2.  Risk factors of HIV vertical transmission in a cohort of women under a PMTCT program at three peri-urban clinics in a resource-poor setting.

Authors:  F Z Gumbo; K Duri; G Q Kandawasvika; N E Kurewa; M P Mapingure; M W Munjoma; S Rusakaniko; M Z Chirenje; B Stray-Pedersen
Journal:  J Perinatol       Date:  2010-03-25       Impact factor: 2.521

Review 3.  p24 revisited: a landscape review of antigen detection for early HIV diagnosis.

Authors:  Eleanor R Gray; Robert Bain; Olivia Varsaneux; Rosanna W Peeling; Molly M Stevens; Rachel A McKendry
Journal:  AIDS       Date:  2018-09-24       Impact factor: 4.177

4.  Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysis.

Authors:  Helen Payne; Nonhlanhla Mkhize; Kennedy Otwombe; Joanna Lewis; Ravindre Panchia; Robin Callard; Lynn Morris; Abdel Babiker; Avy Violari; Mark F Cotton; Nigel J Klein; Diana M Gibb
Journal:  Lancet Infect Dis       Date:  2015-06-01       Impact factor: 25.071

5.  Reduced HIV transmission at subsequent pregnancy in a resource-poor setting.

Authors:  Felicity Zvanyadza Gumbo; Gwendoline Quintoline Kandawasvika; Kerina Duri; Munyaradzi Paul Mapingure; Nyaradzai Edith Kurewa; Kusum Nathoo; Simbarashe Rusakaniko; Mike Zvavahera Chirenje; Babill Stray-Pedersen
Journal:  Trop Doct       Date:  2011-05-16       Impact factor: 0.731

Review 6.  Digestion assays in allergenicity assessment of transgenic proteins.

Authors:  Rod A Herman; Nicholas P Storer; Yong Gao
Journal:  Environ Health Perspect       Date:  2006-08       Impact factor: 9.031

7.  Promising antibody testing strategies for early infant HIV infection diagnosis in China.

Authors:  Xueli Su; Jun Yao; Yan Jiang; Jie Li; Jianfeng Han; Weidong Sun
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.